Related Experiment Video
Updated: Jul 16, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules
Roberta Piva1, Letizia Penolazzi, Margherita Zennaro
1Department of Biochemistry and Molecular Biology, Section of Molecular Biology, Università degli Studi di Ferrara, Via Fossato di Mortara 74, 44100 Ferrara, Italy.
Abstract:
We review the effects of two transcription factor decoy oligonucleotides on apoptosis of human osteoclasts (OCs). The first decoy molecule was designed to inhibit nuclear factor kappa-B (NF-kappaB) binding to target sequence, the second to increase estrogen receptor (ER) alpha expression. We found that both decoy molecules are potent inducers of apoptosis of human OCs, associated with increase of caspase 3 activity and decrease of interleukin 6 expression. In addition, we provide evidence indicating that these oligonucleotides are active in vivo in inducing OCs apoptosis. Because OCs are essential for skeletal development and remodeling throughout the life of animal and man, the approach described is of potential clinical importance.
Insights
Two decoy oligonucleotides effectively induce apoptosis in human osteoclasts (OCs). This approach shows potential for clinical applications in skeletal health by targeting key cellular pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Osteoclasts (OCs) are crucial for bone remodeling and skeletal development.
- Dysregulation of osteoclast activity is implicated in various skeletal diseases.
- Targeting osteoclast apoptosis is a potential therapeutic strategy for bone disorders.
Purpose of the Study:
- To investigate the effects of two novel transcription factor decoy oligonucleotides on human osteoclast apoptosis.
- To determine the molecular mechanisms underlying the apoptotic response induced by these decoys.
- To assess the in vivo efficacy of these oligonucleotides in inducing osteoclast apoptosis.
Main Methods:
- Utilized transcription factor decoy oligonucleotides designed to inhibit nuclear factor kappa-B (NF-kappaB) and increase estrogen receptor (ER) alpha expression.
- Assessed apoptosis in human osteoclasts (OCs) using specific assays.
- Measured caspase 3 activity and interleukin 6 (IL-6) expression levels.
- Evaluated the in vivo effects of the decoy oligonucleotides.
Main Results:
- Both decoy oligonucleotides demonstrated potent induction of apoptosis in human osteoclasts.
- Apoptosis induction was associated with increased caspase 3 activity.
- A decrease in interleukin 6 (IL-6) expression was observed following decoy treatment.
- Evidence suggests these oligonucleotides are active in vivo, inducing osteoclast apoptosis.
Conclusions:
- Transcription factor decoy oligonucleotides targeting NF-kappaB and ER alpha are effective inducers of human osteoclast apoptosis.
- This targeted induction of apoptosis presents a promising therapeutic approach for conditions involving osteoclast dysfunction.
- The findings highlight the clinical potential of these decoy molecules for managing skeletal health.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Osteoclasts in Bone Remodeling
Caspases
